Immunohistochemistry showed TFE3(+), Ki67(about 8%+), S-100(focal+), CD68(portion+), TTF-1(‐), AE1/AE3(‐), HMB45(‐), P40(‐), SMA(‐), Desmin(‐), CA-IX(+), IN-1(+), and SMARCA4(+), suggesting that the tumor could be associated with TFE3 gene translocation. This evidence concerns the gene TFE3 and neoplasm.